Bosanac P, Dubb J, Walker B, Goldberg M, Agus Z S
J Clin Pharmacol. 1976 Nov-Dec;16(11-12):631-6. doi: 10.1002/j.1552-4604.1976.tb01502.x.
In order to determine the effects of guanabenz upon renal function, clearance studies were performed on hypertensive volunteers during sustained steady-state water diuresis. The data reveal an acute fall in renal hemodynamics and a marked reduction in sodium excretion during the 3rd and 4th hour after administration. Tha antinatriuresis was due to decreased filtration and enhanced distal nephron reabsorption of sodium, principally in association with secretion of potassium. Chronic administration of guanabenz for one week produced a sustained reduction in blood pressure, but there was no change in either body weight or 24-hour urinary sodium excretion. Repeat clearance studies revealed no change with either renal hemodynamics or sodium clearance. The data suggest that the acute antinatriuresis is a transient hemodynamic event and chronic therapy with guanabenz will not be complicated by sodium retention, a feature characteristic of other antihypertensive agents.
为了确定胍那苄对肾功能的影响,在持续性稳态水利尿期间,对高血压志愿者进行了清除率研究。数据显示,给药后第3小时和第4小时,肾血流动力学急剧下降,钠排泄显著减少。钠排泄减少是由于滤过减少和远端肾单位对钠的重吸收增强,主要与钾分泌有关。连续一周服用胍那苄可使血压持续降低,但体重和24小时尿钠排泄均无变化。重复清除率研究显示,肾血流动力学和钠清除率均无变化。数据表明,急性钠排泄减少是一种短暂的血流动力学事件,胍那苄的长期治疗不会因钠潴留而复杂化,这是其他抗高血压药物的一个特征。